Evidence map›Paper›PMID 33389097›Full record

ArticleArchives of gynecology and obstetrics2021

Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China.

Tianli Chang, Su Song, Donghui Huang, Ping Su, Xianjin Xiao, Honggang Li, Aihua Liao, Wenpei Xiang

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tianli Chang *Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Su Song *Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Donghui HuangInstitute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ping SuInstitute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xianjin XiaoInstitute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Honggang LiInstitute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Aihua LiaoInstitute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wenpei XiangInstitute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wpxiang2010@gmail.com.ORCID http://orcid.org/0000-0001-9510-116X
Huazhong University of Science and Technology · CN

Funding

Hubei Provincial Emergency Science and Technology Program for COVID-19 2020FCA037HUST COVID-19 Rapid Response Call Program 2020kfyXGYJ056
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ChinaDisease OutbreaksHumansImmunotherapyLymphocytesSARS-CoV-2COVID-19Lymphocyte immunotherapyRecurrent miscarriageSARS-CoV-2

Identifiers

PMID33389097
PMCPMC7778486
OpenAlexW3119374758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.